Cargando…

Prescription Factors Associated with Medication Non-adherence in Japan Assessed from Leftover Drugs in the SETSUYAKU-BAG Campaign: Focus on Oral Antidiabetic Drugs

Background: Medication adherence has an important influence on health outcomes in patients with chronic diseases. However, few studies have been performed in Japan to determine factors related to medication non-adherence. Objective: The aim of this study was to identify prescription factors related...

Descripción completa

Detalles Bibliográficos
Autores principales: Koyanagi, Kaori, Kubota, Toshio, Kobayashi, Daisuke, Kihara, Taro, Yoshida, Takeo, Miisho, Takamasa, Miura, Tomoko, Sakamoto, Yoshiko, Takaki, Junichi, Seo, Takashi, Shimazoe, Takao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4951482/
https://www.ncbi.nlm.nih.gov/pubmed/27489544
http://dx.doi.org/10.3389/fphar.2016.00212
_version_ 1782443711948390400
author Koyanagi, Kaori
Kubota, Toshio
Kobayashi, Daisuke
Kihara, Taro
Yoshida, Takeo
Miisho, Takamasa
Miura, Tomoko
Sakamoto, Yoshiko
Takaki, Junichi
Seo, Takashi
Shimazoe, Takao
author_facet Koyanagi, Kaori
Kubota, Toshio
Kobayashi, Daisuke
Kihara, Taro
Yoshida, Takeo
Miisho, Takamasa
Miura, Tomoko
Sakamoto, Yoshiko
Takaki, Junichi
Seo, Takashi
Shimazoe, Takao
author_sort Koyanagi, Kaori
collection PubMed
description Background: Medication adherence has an important influence on health outcomes in patients with chronic diseases. However, few studies have been performed in Japan to determine factors related to medication non-adherence. Objective: The aim of this study was to identify prescription factors related to medication non-adherence by investigating patient characteristics, all prescriptions, and prescriptions for oral antidiabetic drugs (OADs). Methods: A retrospective cross-sectional survey of prescription data about implementation of dosing regimen was performed at community pharmacies engaged in appropriate use of leftover drugs. We evaluated the amount of drugs originally prescribed and the reduced amount after use of leftover drugs, and then calculated prescription reduction ratio (PRR). We analyzed prescription factors contributing to non-adherence based on the PRR. Results: Prescription information for 1207 patients was reviewed, revealing that patients were non-adherent to 58% of prescriptions. Lack of a drug copayment, fewer concurrent drugs, and drugs not in single-dose packaging were associated with non-adherence. Among the 1207 patients, 234 prescriptions for diabetes and 452 OAD formulations were included. Forty-seven percent of prescriptions and 29% of the formulations were non-adherent. A higher dosing frequency and preprandial administration were associated with non-adherence. Among the OADs, adherence was lower for α-glucosidase inhibitors and biguanides than for sulfonylureas. Conclusions: Several factors related to patient characteristics, general drug prescriptions, and OAD prescriptions were associated with non-adherence. Further consideration will be needed to improve adherence to medication in Japan. Health care providers should perform more careful monitoring of adherence in patients with the factors identified by this study.
format Online
Article
Text
id pubmed-4951482
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-49514822016-08-03 Prescription Factors Associated with Medication Non-adherence in Japan Assessed from Leftover Drugs in the SETSUYAKU-BAG Campaign: Focus on Oral Antidiabetic Drugs Koyanagi, Kaori Kubota, Toshio Kobayashi, Daisuke Kihara, Taro Yoshida, Takeo Miisho, Takamasa Miura, Tomoko Sakamoto, Yoshiko Takaki, Junichi Seo, Takashi Shimazoe, Takao Front Pharmacol Pharmacology Background: Medication adherence has an important influence on health outcomes in patients with chronic diseases. However, few studies have been performed in Japan to determine factors related to medication non-adherence. Objective: The aim of this study was to identify prescription factors related to medication non-adherence by investigating patient characteristics, all prescriptions, and prescriptions for oral antidiabetic drugs (OADs). Methods: A retrospective cross-sectional survey of prescription data about implementation of dosing regimen was performed at community pharmacies engaged in appropriate use of leftover drugs. We evaluated the amount of drugs originally prescribed and the reduced amount after use of leftover drugs, and then calculated prescription reduction ratio (PRR). We analyzed prescription factors contributing to non-adherence based on the PRR. Results: Prescription information for 1207 patients was reviewed, revealing that patients were non-adherent to 58% of prescriptions. Lack of a drug copayment, fewer concurrent drugs, and drugs not in single-dose packaging were associated with non-adherence. Among the 1207 patients, 234 prescriptions for diabetes and 452 OAD formulations were included. Forty-seven percent of prescriptions and 29% of the formulations were non-adherent. A higher dosing frequency and preprandial administration were associated with non-adherence. Among the OADs, adherence was lower for α-glucosidase inhibitors and biguanides than for sulfonylureas. Conclusions: Several factors related to patient characteristics, general drug prescriptions, and OAD prescriptions were associated with non-adherence. Further consideration will be needed to improve adherence to medication in Japan. Health care providers should perform more careful monitoring of adherence in patients with the factors identified by this study. Frontiers Media S.A. 2016-07-20 /pmc/articles/PMC4951482/ /pubmed/27489544 http://dx.doi.org/10.3389/fphar.2016.00212 Text en Copyright © 2016 Koyanagi, Kubota, Kobayashi, Kihara, Yoshida, Miisho, Miura, Sakamoto, Takaki, Seo and Shimazoe. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Koyanagi, Kaori
Kubota, Toshio
Kobayashi, Daisuke
Kihara, Taro
Yoshida, Takeo
Miisho, Takamasa
Miura, Tomoko
Sakamoto, Yoshiko
Takaki, Junichi
Seo, Takashi
Shimazoe, Takao
Prescription Factors Associated with Medication Non-adherence in Japan Assessed from Leftover Drugs in the SETSUYAKU-BAG Campaign: Focus on Oral Antidiabetic Drugs
title Prescription Factors Associated with Medication Non-adherence in Japan Assessed from Leftover Drugs in the SETSUYAKU-BAG Campaign: Focus on Oral Antidiabetic Drugs
title_full Prescription Factors Associated with Medication Non-adherence in Japan Assessed from Leftover Drugs in the SETSUYAKU-BAG Campaign: Focus on Oral Antidiabetic Drugs
title_fullStr Prescription Factors Associated with Medication Non-adherence in Japan Assessed from Leftover Drugs in the SETSUYAKU-BAG Campaign: Focus on Oral Antidiabetic Drugs
title_full_unstemmed Prescription Factors Associated with Medication Non-adherence in Japan Assessed from Leftover Drugs in the SETSUYAKU-BAG Campaign: Focus on Oral Antidiabetic Drugs
title_short Prescription Factors Associated with Medication Non-adherence in Japan Assessed from Leftover Drugs in the SETSUYAKU-BAG Campaign: Focus on Oral Antidiabetic Drugs
title_sort prescription factors associated with medication non-adherence in japan assessed from leftover drugs in the setsuyaku-bag campaign: focus on oral antidiabetic drugs
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4951482/
https://www.ncbi.nlm.nih.gov/pubmed/27489544
http://dx.doi.org/10.3389/fphar.2016.00212
work_keys_str_mv AT koyanagikaori prescriptionfactorsassociatedwithmedicationnonadherenceinjapanassessedfromleftoverdrugsinthesetsuyakubagcampaignfocusonoralantidiabeticdrugs
AT kubotatoshio prescriptionfactorsassociatedwithmedicationnonadherenceinjapanassessedfromleftoverdrugsinthesetsuyakubagcampaignfocusonoralantidiabeticdrugs
AT kobayashidaisuke prescriptionfactorsassociatedwithmedicationnonadherenceinjapanassessedfromleftoverdrugsinthesetsuyakubagcampaignfocusonoralantidiabeticdrugs
AT kiharataro prescriptionfactorsassociatedwithmedicationnonadherenceinjapanassessedfromleftoverdrugsinthesetsuyakubagcampaignfocusonoralantidiabeticdrugs
AT yoshidatakeo prescriptionfactorsassociatedwithmedicationnonadherenceinjapanassessedfromleftoverdrugsinthesetsuyakubagcampaignfocusonoralantidiabeticdrugs
AT miishotakamasa prescriptionfactorsassociatedwithmedicationnonadherenceinjapanassessedfromleftoverdrugsinthesetsuyakubagcampaignfocusonoralantidiabeticdrugs
AT miuratomoko prescriptionfactorsassociatedwithmedicationnonadherenceinjapanassessedfromleftoverdrugsinthesetsuyakubagcampaignfocusonoralantidiabeticdrugs
AT sakamotoyoshiko prescriptionfactorsassociatedwithmedicationnonadherenceinjapanassessedfromleftoverdrugsinthesetsuyakubagcampaignfocusonoralantidiabeticdrugs
AT takakijunichi prescriptionfactorsassociatedwithmedicationnonadherenceinjapanassessedfromleftoverdrugsinthesetsuyakubagcampaignfocusonoralantidiabeticdrugs
AT seotakashi prescriptionfactorsassociatedwithmedicationnonadherenceinjapanassessedfromleftoverdrugsinthesetsuyakubagcampaignfocusonoralantidiabeticdrugs
AT shimazoetakao prescriptionfactorsassociatedwithmedicationnonadherenceinjapanassessedfromleftoverdrugsinthesetsuyakubagcampaignfocusonoralantidiabeticdrugs